Labrador Retriever Received VetStem Cell Therapy for Fragmented Coronoid Process in Elbows

Nicholas Augustus

Niko, a Labrador retriever, was successfully treated with VetStem cell therapy in conjunction with surgery for a fragmented coronoid process (FCP) in his elbows.

A year after surgery and stem cell therapy, Niko runs and plays with the energy of a 3-year-old. ”

— Niko’s owner

POWAY, California, USA, Nov. 1, 2022 / — Nikolai Augustus, a Labrador retriever, was 2 years old when he started limping. X-rays revealed he had broken bone fragments in both of his elbows from a fragmented coronoid process, or FCP. FCP is one of the major diseases associated with elbow dysplasia. It is a defect in the development of the two small bony projections at the end of the ulna, known as the coronoid processes, in the elbow joint. In this condition, one of the bony protrusions develops a fissure or fissure and separates from the ulna. FCP can cause instability and pain as well as decreased mobility and swelling.

The treatment of choice for FCP is the surgical removal of bone fragments and any abnormal cartilage. This procedure can be performed arthroscopically by an orthopedic surgeon, resulting in a smaller incision and less damage to elbow support structures. In all cases however, regardless of surgical repair, the patient will develop some degree of arthritis.

Luckily for Niko, her vet recommended an arthroscopy in addition to the VetStem Cell Therapy treatment. Stem cells are regenerative cells that can differentiate into many tissue types and have been shown to reduce pain and inflammation, restore range of motion, and stimulate regeneration of tendons, ligaments, and joints. joint tissues. In a peer-reviewed study of dogs with chronic elbow osteoarthritis, treatment with stem cells was found to reduce pain and lameness. By using VetStem cell therapy in conjunction with surgery, Niko’s vet hoped to delay the progression and reduce the severity of degenerative joint disease in his elbows.

To begin the process, Niko’s vet removed fatty tissue from his abdomen during a minimally invasive anesthetic procedure. The fat was aseptically packaged and shipped to the VetStem processing lab in Poway, CA. Lab technicians processed the fat to extract and concentrate the stem and regenerative cells it contains. The cells were divided into doses and two injectable doses were shipped to Niko’s vet for processing. About 48 hours after the initial fat harvesting procedure, Niko received a dose of his own stem cells in each elbow.

According to Niko’s owner, he responded very well to the treatment. His owner said: “One year after surgery and stem cell therapy, Niko is running and playing with the energy of a 3 year old. We are grateful that our vet recommended stem cell therapy for Niko and that he has the stem cell bank to help treat Niko in the future.

In addition to the two doses of stem cells that were shipped for immediate processing, several doses of Niko’s stem cells were put in cryopreservation. This is especially valuable for a patient like Niko who will never have perfect, arthritis-free elbows. In fact, about 15 months after his initial treatment, Niko received a follow-up treatment identical to the first using some of his banked stem cell doses. Niko’s extra cells will remain in cryopreservation and can be accessed for treatment as needed for the rest of his life. Learn more at

About VetStem, Inc.
VetStem is a veterinarian-led company that was established in 2002 to bring regenerative medicine to the profession. This private biopharmaceutical company, based near San Diego, Calif., currently offers veterinarians a service of treating autologous stem cells (derived from patients’ adipose tissue) among other regeneration modalities. With unique expertise acquired over the past 15 years and thousands of treatments by veterinarians for joint, tendon and ligament problems, VetStem has made applications of regenerative medicine a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that take advantage of the natural restorative abilities found in all living creatures. In addition to its own patent portfolio, VetStem holds exclusive worldwide veterinary licenses for a large portfolio of issued patents in the field of regenerative medicine.

Kristi Hauta, Director of Business Operations
VetStem, Inc.
+1 858-748-2004
write to us here